1. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion. Gastroenterology. 1980; 78(5 Pt 1):991–5.
Article
2. Pelham RW, Nix LC, Chavira RE, Cleveland MV, Stetson P. Clinical trial: single-and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects. Aliment Pharmacol Ther. 2008; 28:256–65.
3. Winne D, Görig H. Appearance of 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination. Naunyn Schmiedebergs Arch Pharmacol. 1982; 321:149–56.
Article
4. Schiller LR, Emmett M, Santa Ana CA, Fordtran JS. Osmotic effects of polyethylene glycol. Gastroenterology. 1988; 94:933–41.
Article
5. Pellegrini G, Starkey Lewis PJ, Palmer L, Hetzel U, Goldring CE, Park BK, et al. Intraperitoneal administration of high doses of polyethylene glycol (PEG) causes hepatic subcapsular necrosis and low-grade peritonitis with a rise in hepatic biomarkers. Toxicology. 2013; 314:262–6.
Article